Approval · Notice of Compliance 4431 · 1996
PROHANCE: Notice of Compliance 4431
Issued August 19, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4431
- Date
- August 19, 1996
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Contrast enhancement preparation for magnetic resonance imaging
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROHANCE | 02229056 | Marketed |
Medicinal ingredients
- GADOTERIDOL 279.3 MG per ML